---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-349353"
form_type: "8-K"
ticker: "ABCL"
cik: "0001703057"
company_name: "AbCellera Biologics Inc."
filed_at: "2026-08-13T20:33:34+00:00"
generated_at: "2026-08-13T20:34:16.404711+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# AbCellera prices $200M public offering of common shares and pre-funded warrants

## Summary
- 17,435,897 common shares at $9.75/share and 3,076,926 pre-funded warrants at $9.74999 each.
- Gross proceeds ~$200M; net proceeds ~$187M after underwriting discounts and estimated expenses.
- Proceeds to fund internal pipeline including lead program ABCL635, plus working capital and general corporate purposes.
- Offering expected to close Aug 14, 2026; Jefferies, J.P. Morgan, Cantor, UBS, BMO act as joint book-runners.
- Company and insiders subject to 60-day lock-up on share sales following the underwriting agreement.

## SEC filing metadata
- accession: 0001193125-26-349353
- form_type: 8-K
- ticker: ABCL
- cik: 0001703057
- company_name: AbCellera Biologics Inc.
- filed_at: 2026-08-13T20:33:34+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1703057/000119312526349353/0001193125-26-349353-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1703057/000119312526349353/d20959d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-349353
- JSON: https://secwatch.observer/filing/0001193125-26-349353.json
- Plain text: https://secwatch.observer/filing/0001193125-26-349353.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.